Does Rallies show 13F holders for ATR?

Yes. Rallies tracks hedge fund and 13F ownership data for ATR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ATR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ATR. It does not provide personalized investment advice.

ATR (AptarGroup, Inc.) Stock Analysis - Hedge Fund Holdings

AptarGroup, Inc. (ATR) is a publicly traded Healthcare sector company. As of May 21, 2026, ATR trades at $115.24 with a market cap of $7.39B and a P/E ratio of 19.45. ATR moved +1.27% today. Year to date, ATR is -6.29%; over the trailing twelve months it is -27.29%. Its 52-week range spans $103.23 to $178.03. Analyst consensus is buy with an average price target of $145.80. Rallies surfaces ATR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ATR stock?

Hedge funds tracked by Rallies that own ATR include Bridgewater Associates, Centerbook Partners, Panagora Asset, Pinebridge Investments, and Maverick Capital. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AptarGroup, Inc..

ATR Key Metrics

Key financial metrics for ATR
Metric	Value
Price	$115.24
Market Cap	$7.39B
P/E Ratio	19.45
EPS	$5.91
Dividend Yield	0.48%
52-Week High	$178.03
52-Week Low	$103.23
Volume	183
Avg Volume	0
Revenue (TTM)	$3.87B
Net Income	$386.60M
Gross Margin	0.00%

Top Hedge Funds Holding ATR

Bridgewater Associates holds 18.57K shares of ATR, changed +0.00% as of Sep 30, 2025.
Centerbook Partners holds 11.32K shares of ATR, changed +0.00% as of Mar 31, 2026.
Panagora Asset holds 9.24K shares of ATR, changed -74.93% as of Mar 31, 2026.
Pinebridge Investments holds 6.78K shares of ATR, changed -69.13% as of Mar 31, 2025.
Maverick Capital holds 2.49K shares of ATR, changed +0.00% as of Dec 31, 2023.

Latest ATR News

AptarGroup drops after Q1 profit and margins slide on pharma destocking — May 1, 2026
AptarGroup Q1 Sales Up 11% to $982.9M, Adjusted EPS $1.19 — Apr 30, 2026
AptarGroup drops as 2026 emergency-medicine destocking and margin pressure weigh — Apr 21, 2026
AptarGroup jumps as Wall Street upgrade lifts target to $144 — Apr 8, 2026
AptarGroup Q4 Sales Up 14% to $963M, Board Authorizes $600M Buyback — Feb 6, 2026

Recent ATR Insider Trades

Hudson Irene Elizabeth sold 422 (~$52.07K) on May 7, 2026.
Hudson Irene Elizabeth sold 842 (~$103.95K) on May 7, 2026.

ATR Analyst Consensus

5 analysts cover ATR: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $145.80.

Common questions about ATR

Who owns ATR stock?: Hedge funds tracked by Rallies that own ATR include Bridgewater Associates, Centerbook Partners, Panagora Asset, Pinebridge Investments, and Maverick Capital. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AptarGroup, Inc..
Does Rallies show 13F holders for ATR?: Yes. Rallies tracks hedge fund and 13F ownership data for ATR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ATR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ATR. It does not provide personalized investment advice.